Cardiotoxicity of Contemporary Anticancer Immunotherapy

PURPOSE OF REVIEW: Contemporary anticancer immunotherapy, particularly immune checkpoint inhibitors (ICI) and chimeric antigen receptor (CAR) T cell therapy, has changed the landscape of treatment for patients with a variety of malignancies who historically had a poor prognosis. However, both immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Dal’bo, Natalie, Patel, Rushin, Parikh, Rohan, Shah, Sachin P., Guha, Avirup, Dani, Sourbha S., Ganatra, Sarju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Cardio-oncology (M Fradley, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605901/
https://www.ncbi.nlm.nih.gov/pubmed/33162729
http://dx.doi.org/10.1007/s11936-020-00867-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605901/
https://www.ncbi.nlm.nih.gov/pubmed/33162729
http://dx.doi.org/10.1007/s11936-020-00867-1

Ejemplares similares